Here are the DEF 14A proxy statements from Bayview Acquisition Corp Right (BAYAR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow BAYAR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BAYAR filings page.
Bayview Acquisition Corp is asking shareholders to approve three proposals at a May 28, 2026 extraordinary general meeting. The main goal is to extend the deadline to complete a Business Combination from June 19, 2026 to December 19, 2026, with up to six one‑month extensions funded by $50,000 monthly deposits into the trust account.
Public shareholders can redeem their shares for cash in connection with the vote. As of the record date, the redemption price was approximately $12.03 per Public Share, based on about $12.1 million held in the Trust Account, versus a $12.00 Nasdaq trading price. If the extensions are not approved and no deal closes by June 19, 2026, Bayview will redeem all Public Shares and liquidate.
Bayview Acquisition Corp, a Cayman Islands SPAC, is asking shareholders to approve routine annual matters at an April 10, 2026 meeting. Proposals include re-electing Class I director John Joseph DeVito for a three-year term, ratifying UHY LLP as auditor for 2026, and allowing potential adjournment if votes are insufficient.
The meeting will be held in Houston and via webcast, with one vote per ordinary share and a one-third quorum requirement. Sponsors, directors, officers and affiliates control about 1,732,500 shares, or roughly 50% of outstanding ordinary shares, meaning no public shares are needed to pass any of the proposals if all shares are present.
Bayview remains a pre-revenue blank check company focused on completing an initial business combination, primarily targeting Asia. It has already signed a definitive agreement for a business combination and will seek separate shareholder approval in a future proxy statement. The proxy also highlights SPAC-specific regulatory, investment company, CFIUS and Nasdaq listing-compliance risks.